Literature DB >> 11531873

Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy.

C E Mountford1, R L Somorjai, P Malycha, L Gluch, C Lean, P Russell, B Barraclough, D Gillett, U Himmelreich, B Dolenko, A E Nikulin, I C Smith.   

Abstract

BACKGROUND: The aim was to develop robust classifiers to analyse magnetic resonance spectroscopy (MRS) data of fine-needle aspirates taken from breast tumours. The resulting data could provide computerized, classification-based diagnosis and prognostic indicators.
METHODS: Fine-needle aspirate biopsies obtained at the time of surgery for both benign and malignant breast diseases were analysed by one-dimensional proton MRS at 8.5 Tesla. Diagnostic correlation was performed between the spectra and standard pathology reports, including the presence of vascular invasion by the primary cancer and involvement of the excised axillary lymph nodes.
RESULTS: Malignant tissue was distinguished from benign lesions with an overall accuracy of 93 per cent. From the same spectra, lymph node involvement was predicted with an overall accuracy of 95 per cent, and tumour vascular invasion with an overall accuracy of 94 per cent.
CONCLUSION: The pathology, nodal involvement and tumour vascular invasion were predicted by computerized statistical classification of the proton MRS spectrum from a fine-needle aspirate biopsy taken from the primary breast lesion.

Entities:  

Mesh:

Year:  2001        PMID: 11531873     DOI: 10.1046/j.0007-1323.2001.01864.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  29 in total

1.  Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study.

Authors:  Leonardo Tenori; Catherine Oakman; Patrick G Morris; Ewa Gralka; Natalie Turner; Silvia Cappadona; Monica Fornier; Cliff Hudis; Larry Norton; Claudio Luchinat; Angelo Di Leo
Journal:  Mol Oncol       Date:  2014-08-10       Impact factor: 6.603

2.  Prediction of treatment response in head and neck cancer by magnetic resonance spectroscopy.

Authors:  Tedros Bezabeh; Olva Odlum; Richard Nason; Paul Kerr; Donna Sutherland; Rakesh Patel; Ian C P Smith
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

3.  A high spatial resolution 1H magnetic resonance spectroscopic imaging technique for breast cancer with a short echo time.

Authors:  Jiani Hu; Yingjian Yu; Zhifeng Kou; Wei Huang; Quan Jiang; Yang Xuan; Tao Li; Vivek Sehgal; Cassann Blake; E Mark Haacke; Renate L Soulen
Journal:  Magn Reson Imaging       Date:  2007-09-27       Impact factor: 2.546

Review 4.  Metabolite quantification and high-field MRS in breast cancer.

Authors:  Ihab S Haddadin; Adeka McIntosh; Sina Meisamy; Curt Corum; Angela L Styczynski Snyder; Nathaniel J Powell; Michael T Nelson; Douglas Yee; Michael Garwood; Patrick J Bolan
Journal:  NMR Biomed       Date:  2009-01       Impact factor: 4.044

Review 5.  Metabolomics: moving to the clinic.

Authors:  Anders Nordström; Rolf Lewensohn
Journal:  J Neuroimmune Pharmacol       Date:  2009-04-28       Impact factor: 4.147

Review 6.  Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer.

Authors:  Kristine Glunde; Dmitri Artemov; Marie-France Penet; Michael A Jacobs; Zaver M Bhujwalla
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 7.  Breast Cancer Metabolism.

Authors:  Jessica Tan; Anne Le
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

8.  1H NMR analysis of choline metabolites in fine-needle-aspirate biopsies of breast cancer.

Authors:  John M Pearce; Mary C Mahoney; Jing-Huei Lee; Wen-Jang Chu; Kim M Cecil; Stephen M Strakowski; Richard A Komoroski
Journal:  MAGMA       Date:  2012-10-05       Impact factor: 2.310

Review 9.  Biochemical characterization of breast tumors by in vivo and in vitro magnetic resonance spectroscopy (MRS).

Authors:  Uma Sharma; Naranamangalam R Jagannathan
Journal:  Biophys Rev       Date:  2009-01-17

10.  Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T.

Authors:  Peter Stanwell; Laurence Gluch; David Clark; Boguslaw Tomanek; Luke Baker; Bruno Giuffrè; Cynthia Lean; Peter Malycha; Carolyn Mountford
Journal:  Eur Radiol       Date:  2004-09-03       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.